FilingReader Intelligence
Yiling Pharmaceutical receives acceptance for new drug application
July 10, 2025 at 09:11 AM UTC•By FilingReader AI
Shijiazhuang Yiling Pharmaceutical announced that it has received an acceptance notice from the NMPA for its drug registration application for Banxia Baizhu Tianma Granules, a TCM formula derived from the "Ancient Classical Formulae List" (First Batch) released in April 2018.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SZSE:002603•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Shijiazhuang Yiling Pharmaceutical publishes news
Free account required • Unsubscribe anytime